The selective inhibition of IDO reversed ICV-STZ-induced depression-like behaviors by ameliorating neuroprotective branch deficits in the PrL and inhibiting neurotoxicogenic branch overactivation in the IL. The gene discussed is IDO1; the disease is depressive symptom measurement.